Inhibition of the primary lesion of adjuvant. induced polyarthritis in rats (18-hour arthritis test) for specific detection of clinically effective anti-arthritic drugs
- PMID: 807714
Inhibition of the primary lesion of adjuvant. induced polyarthritis in rats (18-hour arthritis test) for specific detection of clinically effective anti-arthritic drugs
Abstract
Adjuvant-induced polyarthritis can be induced in rats 14 to 21 days after subplantar injection of 0.1 ml of a 0.5% suspension of Mycobacterium tuberculosis in heavy mineral oil into a hind paw. However, edema volume of the injected pay (primary lesion) developed rapidly and reached a peak in 18 hours after injection and persisted at this level for up to 90 hours. A single oral dose of 25 clinically effective or experimental antiarthritic agents given 1 hour prior to M. tuberculosis injection and tested 18 hours later significantly inhibited edema formation in a dose-related fashion. Only D-penicillamine and azathioprine which are clinically effected, gave false-negative responses in this test. However, cyclophosphamide, another immunosuppressive like azathioprine, was effective. The ED50 values for most drugs in this test were at least 2-fold greater than in the carrageenan edema test. On the other hand, of the 17 drugs considered as false-positives in the carrageenan test only the antihistaminic agent, chlorpheniramine maleate, was effective in the 18-hour arthritis test, whereas several other agents with this activity but different chemical structure proved ineffective. In addition, 18 other agents from various classes of therapeutic agents were also tested and found ineffective in each test. These data suggest that the 18-hour arthritis test in rats is highly specific and a more reliable screening procedure than carrageenan-induced edema for detecting potentially useful antiarthritic agents. The practical advantages of this method are also discussed.
Similar articles
-
Use of Freund's adjuvant arthritis test in anti-flammatory drug screening in the rat: value of animal selection and preparation at the breeding center.Lab Anim Sci. 1976 Apr;26(2 Pt 2):281-7. Lab Anim Sci. 1976. PMID: 131876
-
Lipopolysaccharide-induced paw edema model for detection of cytokine modulating anti-inflammatory agents.Int Immunopharmacol. 2004 Jul;4(7):901-9. doi: 10.1016/j.intimp.2004.04.007. Int Immunopharmacol. 2004. PMID: 15182729
-
Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.Scand J Immunol. 2005 May;61(5):435-41. doi: 10.1111/j.1365-3083.2005.01594.x. Scand J Immunol. 2005. PMID: 15882435
-
Interaction of allopurinol and non-steroidal anti-inflammatory drugs on the carrageenan-induced rat paw edema.Saudi Med J. 2003 Sep;24(9):936-40. Saudi Med J. 2003. PMID: 12973472
-
Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.Int J Toxicol. 2007;26 Suppl 1:3-106. doi: 10.1080/10915810601163939. Int J Toxicol. 2007. PMID: 17365137 Review.
Cited by
-
Evaluation of some standard arthritogenic adjuvants ('modified perrigens') in male rats.Agents Actions. 1977 Oct;7(4):459-63. doi: 10.1007/BF01966853. Agents Actions. 1977. PMID: 412400
-
Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.Drugs. 1978 Jun;15(6):429-50. doi: 10.2165/00003495-197815060-00002. Drugs. 1978. PMID: 350558 Review. No abstract available.
-
Arthritis in mice induced by a single immunisation with collagen.Ann Rheum Dis. 1996 Aug;55(8):535-9. doi: 10.1136/ard.55.8.535. Ann Rheum Dis. 1996. PMID: 8774181 Free PMC article.
-
Antibody-induced foot oedema, hyperalgesia and monoarticular arthritis in rats, guinea-pigs and rabbits for testing anti-inflammatory, antiarthritic agents.Agents Actions. 1981 Dec;11(6-7):750-61. doi: 10.1007/BF01978801. Agents Actions. 1981. PMID: 7340468
-
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.Drugs. 1979 Oct;18(4):241-77. doi: 10.2165/00003495-197918040-00001. Drugs. 1979. PMID: 387372 Review.